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July 2012278 AbstractsCEA. The authors preformed an evaluation of perioperative and long-term
outcomes of CAS and CEA in patients with previous cervical radiation
therapy. They used a systematic search strategy with the synonyms “carotid
artery stenosis” and “cervical irradiation” in MEDLINE and Embase data-
bases. Pooled and meta-regression analysis was performed to provide and
compare estimates of outcomes. There were 27 articles comprising 533
patients undergoing radiation therapy (361 CAS and 172 CEA) that fulfilled
inclusion criteria. Pooled analysis showed a perioperative risk for any cerebral
vascular adverse event (CVAE) of 3.9% (95% confidence interval [CI],
2.3%-6.7%) in CAS studies vs 3.5% (95%CI, 1.5%-8.0%) in CEA studies (P
.77). Risk for cranial nerve injury after CEA was 9.2% (95% CI, 3.7%-21.1%)
vs none after CAS. Late outcome showed rates of CVAE favoring CEA (P
.014). The rate of restenosis 50% was higher in patients treated with CAS
compared with CEA (P .003). Of the nine cranial nerve injuries identified
after CEA, only one was permanent, with the remainder resolving within a
few weeks of operation.
Comment: The article questions the commonly held assumption that
CAS is preferred for treatment of carotid stenosis over CEA in patients with
previous cervical radiation. The main problem with this study is a high
possibility of selection bias, with individuals with worse radiation injury
being treated with CAS and those with less injury treated with CEA. The
report therefore cannot indicate a preferred revascularization strategy in
patients requiring treatment of carotid stenosis with previous cervical radi-
ation. The rate of adverse events is relatively low in both groups; therefore,
the choice of treatment with CAS or CEA for carotid stenosis in patients
with previous cervical radiation remains an individual treatment decision
based on physician judgment. Both forms of treatment can provide reason-
able results in appropriate patients.
Retrospective Analysis of Surgery Versus Endovascular Intervention in
Takayasu Arteritis: A Multicenter Experience
Saadoun D, Lambert M, Mirault T, et al. Circulation 2012;125:813-9.
Conclusion: The overall 5-year arterial complication rate after surgical
or endovascular intervention for Takayasu arteritis (TA) is 44%. Complica-
tions are increased with the presence of biologic inflammation in patients
with TA.
Summary: TA is a well known but infrequently encountered large-
vessel arteritis predominately affecting the aorta and its primary branches. It
affects both sexes, and multiple ethnic and racial groups worldwide. Unlike
the temporal arteritis variant of giant cell arteritis, TA responds less well to
glucocorticoid treatment, with remissions occurring in only 40% to 60% of
patients (Kerr GS et al, Ann Intern Med 1994;120:919-29). Of the steroid-
resistant patients, about 40% will respond to additional cytotoxic agents,
leaving approximately 20% of all TA patients resistant to treatment (Hoff-
b
tan GS et al, Arthritis Rheum 2004;50:2296-304). Conventional wisdom
as been that surgical reconstruction for TA does best in the absence of signs
f inflammation and that endovascular treatment for TA is less likely to be
uccessful. Long-term outcomes of endovascular treatment, however, have
ot been reported (Ogino H et al, Circulation 2008;118:2738-47), and a
uantitative assessment of the adequacy of anti-inflammatory treatment for
ascular intervention for TA is also relatively unknown. In particular, data for
ndovascular treatments of this disease consist primarily of case reports from
mall series. In this report, the authors present a relatively large series of TA
atients with long-term outcome analysis after revascularization procedures.
his retrospective multicenter study analyzed the results and outcomes of 79
onsecutive TA patients, 63 women (79.7%), with a median age of 39 years
interquartile range [IQR], 25-50 years). These patients underwent 166
ascular procedures, comprising surgery in 104 (62.7%) and endovascular
epairs in 62 (37.3%). After a follow-up of 6.5 years (IQR 2.2-11.5 years),
here were 70 complications observed, including 53 restenosis, seven throm-
osis, six bleeding complications, and four strokes. Overall, the arterial
omplication-free survival rates at 1, 3, 5, and 10 years were, respectively,
8% (IQR, 69%-88%), 67% (IQR, 57%-78%), 56% (IQR 46%-70%), and 45%
IQR, 34%-60%). The incidence of complications was 37.5% among the 104
urgical procedures and 50% among the 62 endovascular procedures. Mul-
ivariate analysis indicated that inflammation at the time of revascularization
odds ratio, 7.48; 95% confidence interval, 1.42-39.39; P  .04) was
ndependently associated with arterial complications after the vascular pro-
edure. Patients with complications had higher erythrocyte sedimentation
ates (P .001) and serum levels of C-reactive protein levels (P .001) and
brinogen (P .005) compared with patients without arterial complications
fter the vascular procedure.
Comment: Endovascular therapies for TA have traditionally been
egarded as inferior to surgical therapies, with restenosis rates in previous
eries approximately double those of surgical reconstructions (Maksimow-
cz-Mckinnon K et al, Arthritis Rheum 2007;56:1000-9). The current
tudy, which is larger and with longer follow-up than previous studies,
uggests underlying biologic inflammation rather than the type of therapy
sed for TA disease is the most important determinant of complications after
rterial reconstruction in TA patients. Complication rates were 61.5% and
4% for endovascular repair and surgical repair, respectively, when there was
vidence of biologic inflammation. Of course, none of the data here were
andomized, and the patients were treated at various stages of their disease.
n addition, there are insufficient numbers of surgical and endovascular
econstructions for specific arteries and at specific points of disease activity to
ake definitive conclusions about the relative durability of each type of
econstruction. The principal point of the report is that regardless of whether
he patient with TA disease is treated with surgical or endovascular therapy,
iologic inflammation at the time of revascularization dramatically increases
he likelihood of complication.
